These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26833215)

  • 1. Therapeutic Strategies for the Treatment of Severe Cushing's Syndrome.
    Alexandraki KI; Grossman AB
    Drugs; 2016 Mar; 76(4):447-58. PubMed ID: 26833215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current strategies for the treatment of severe Cushing's syndrome.
    Alexandraki KI; Grossman AB
    Expert Rev Endocrinol Metab; 2016 Jan; 11(1):65-79. PubMed ID: 30063449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole.
    Feelders RA; Hofland LJ; de Herder WW
    Neuroendocrinology; 2010; 92 Suppl 1():111-5. PubMed ID: 20829630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
    Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients.
    Daniel E; Aylwin S; Mustafa O; Ball S; Munir A; Boelaert K; Chortis V; Cuthbertson DJ; Daousi C; Rajeev SP; Davis J; Cheer K; Drake W; Gunganah K; Grossman A; Gurnell M; Powlson AS; Karavitaki N; Huguet I; Kearney T; Mohit K; Meeran K; Hill N; Rees A; Lansdown AJ; Trainer PJ; Minder AE; Newell-Price J
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4146-54. PubMed ID: 26353009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease.
    Greening JE; Brain CE; Perry LA; Mushtaq I; Sales Marques J; Grossman AB; Savage MO
    Horm Res; 2005; 64(3):140-3. PubMed ID: 16192738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
    Engelhardt D; Weber MM
    J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):261-7. PubMed ID: 8043488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs in the medical treatment of Cushing's syndrome.
    Schteingart DE
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonhypnotic low-dose etomidate for rapid correction of hypercortisolaemia in Cushing's syndrome.
    Allolio B; Schulte HM; Kaulen D; Reincke M; Jaursch-Hancke C; Winkelmann W
    Klin Wochenschr; 1988 Apr; 66(8):361-4. PubMed ID: 3392892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etomidate in the management of hypercortisolaemia in Cushing's syndrome: a review.
    Preda VA; Sen J; Karavitaki N; Grossman AB
    Eur J Endocrinol; 2012 Aug; 167(2):137-43. PubMed ID: 22577107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intravenous etomidate to control acute psychosis induced by the hypercortisolaemia in severe paediatric Cushing's disease.
    Chan LF; Vaidya M; Westphal B; Allgrove J; Martin L; Afshar F; Hindmarsh PC; Savage MO; Grossman AB; Storr HL
    Horm Res Paediatr; 2011; 75(6):441-6. PubMed ID: 21430362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medical treatment for Cushing's syndrome].
    Nishikawa T; Saito J; Omura M
    Nihon Rinsho; 2008 Jan; 66(1):186-91. PubMed ID: 18186263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketoconazole treatment in Cushing's syndrome: experience in 34 patients.
    Sonino N; Boscaro M; Paoletta A; Mantero F; Ziliotto D
    Clin Endocrinol (Oxf); 1991 Oct; 35(4):347-52. PubMed ID: 1752063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The medical management of Cushing's syndrome during pregnancy.
    Lim WH; Torpy DJ; Jeffries WS
    Eur J Obstet Gynecol Reprod Biol; 2013 May; 168(1):1-6. PubMed ID: 23305861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etomidate use for Cushing's syndrome caused by an ectopic adrenocorticotropic hormone-producing tumor.
    Johnson TN; Canada TW
    Ann Pharmacother; 2007 Feb; 41(2):350-3. PubMed ID: 17213295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous Etomidate for the Management of Cushing's Syndrome Complicated by Pulmonary Nocardiosis.
    Hays WB; Czosnowski Q
    J Pharm Pract; 2022 Dec; 35(6):1057-1059. PubMed ID: 34056961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A successful case of pregnancy in a woman with ACTH-independent Cushing's syndrome treated with ketoconazole and metyrapone.
    Zieleniewski W; Michalak R
    Gynecol Endocrinol; 2017 May; 33(5):349-352. PubMed ID: 28277127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates in adrenal steroidogenesis inhibitors for Cushing's syndrome - A practical guide.
    Varlamov EV; Han AJ; Fleseriu M
    Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101490. PubMed ID: 33707082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cushing's disease: adrenal steroidogenesis inhibitors.
    Pivonello R; Simeoli C; Di Paola N; Colao A
    Pituitary; 2022 Oct; 25(5):726-732. PubMed ID: 36036308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumocystis pneumonia during medicamentous treatment of Cushing's syndrome--a description of two cases.
    Gabalec F; Zavrelová A; Havel E; Cerman J; Radocha J; Svilias I; Cáp J
    Acta Medica (Hradec Kralove); 2011; 54(3):127-30. PubMed ID: 22250484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.